Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Cell Biology >> Apoptosis >> Intracellular >> Associated Proteins
Anti-GTPase HRAS antibody [H-Ras-03] - Activation site
See all GTPase HRAS products (5) ...
Mouse monoclonal [H-Ras-03] to GTPase HRAS - Activation site
WB, ELISAmore details
Reacts with
Human
Predicted to work with
Mouse, Rat, Horse, Chimpanzee, Zebrafish, Opossum
Synthetic peptide: DIHQYREQIKRVKDSDDC, corresponding to internal sequence amino acids 92-109 of Human GTPase HRAS
DIHQYREQIK RVKDSDDC
RAJI human Burkitt lymphoma cell line HeLa human cervix carcinoma cell line K562 human Caucasian chronic myeloid leukemia cell line
Liquid
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.
Preservative: 15mM Sodium Azide
Constituents: PBS, pH 7.4
Concentration information loading...
Protein A purified
ab64705 was purified from ascites by protein-A affinity chromatography. Purity is >95% by SDS-PAGE.
Monoclonal
H-Ras-03
IgG1
Cancer >> Signal transduction >> G protein signaling >> Small G proteins >> Ras family
Epigenetics and Nuclear Signaling >> Transcription >> Cancer susceptibility >> Proto-oncogenes
Cell Biology >> Cell Cycle >> Cell differentiation
Signal Transduction >> Signaling Pathway >> G Protein Signaling >> Small G Proteins >> Ras Family
Signal Transduction >> Second Messenger >> Nucleotide Messenger >> GTP
Cell Biology >> Apoptosis >> Intracellular >> Associated Proteins
Western blot - GTPase HRAS antibody [H-Ras-03] - Activation site (ab64705)
(enlarge)
Our Abpromise guarantee covers the use of ab64705 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: Use a concentration of 0.5 - 1 µg/ml.Detects a band of approximately 24 kDa (predicted molecular weight: 21 kDa).
ELISA: Use at an assay dependent dilution.
Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
Defects in HRAS are the cause of Costello syndrome (COSTS) [MIM:218040]; also known as faciocutaneoskeletal syndrome. Costello syndrome is a rare condition characterized by prenatally increased growth, postnatal growth deficiency, mental retardation, distinctive facial appearance, cardiovascular abnormalities (typically pulmonic stenosis, hypertrophic cardiomyopathy and/or atrial tachycardia), tumor predisposition, skin and musculoskeletal abnormalities.
Defects in HRAS are the cause of congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040]. CMEMS is a variant of Costello syndrome.
Defects in HRAS may be a cause of susceptibility to Hurthle cell thyroid carcinoma (HCTC) [MIM:607464]. Hurthle cell thyroid carcinoma accounts for approximately 3% of all thyroid cancers. Although they are classified as variants of follicular neoplasms, they are more often multifocal and somewhat more aggressive and are less likely to take up iodine than are other follicular neoplasms.
Note=Mutations which change positions 12, 13 or 61 activate the potential of HRAS to transform cultured cells and are implicated in a variety of human tumors.
Defects in HRAS are a cause of susceptibility to bladder cancer (BLC) [MIM:109800]. A malignancy originating in tissues of the urinary bladder. It often presents with multiple tumors appearing at different times and at different sites in the bladder. Most bladder cancers are transitional cell carcinomas. They begin in cells that normally make up the inner lining of the bladder. Other types of bladder cancer include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Bladder cancer is a complex disorder with both genetic and environmental influences.
Note=Defects in HRAS are the cause of oral squamous cell carcinoma (OSCC).
Belongs to the small GTPase superfamily. Ras family.
Palmitoylated by the ZDHHC9-GOLGA7 complex. A continuous cycle of de- and re-palmitoylation regulates rapid exchange between plasma membrane and Golgi.
S-nitrosylated; critical for redox regulation. Important for stimulating guanine nucleotide exchange. No structural perturbation on nitrosylation.
Cell membrane. Golgi apparatus membrane. Shuttles between the plasma membrane and the Golgi apparatus.
Target information above from: UniProt accessionP01112
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - GTPase HRAS antibody [H-Ras-03] - Activation site (ab64705)
![Western blot - GTPase HRAS antibody [H-Ras-03] - Activation site (ab64705)](/ps/datasheet/Images/64/ab64705/ab64705wb.jpg)
All lanes : Anti-GTPase HRAS antibody [H-Ras-03] - Activation site (ab64705) at 0.5 µg/ml
Lane 1 : HeLa human cervix carcinoma cell line
Lane 2 : K567 human leukemia cell line
Lane 3 : RAJI human Burkitt lymphoma cell line
Performed under reducing conditions.
Predicted band size : 21 kDa
Observed band size : 24 kDa (why is the actual band size different from the predicted?)
ab64705 has not yet been referenced specifically in any publications.
Publishing research using ab64705? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Western blot - GTPase HRAS antibody [H-Ras-03] - Activation site (ab64705)](/ps/datasheet/Images/64/ab64705/ab64705wb.jpg)
All lanes : Anti-GTPase HRAS antibody [H-Ras-03] - Activation site (ab64705) at 0.5 µg/ml
Lane 1 : HeLa human cervix carcinoma cell line
Lane 2 : K567 human leukemia cell line
Lane 3 : RAJI human Burkitt lymphoma cell line
Performed under reducing conditions.
Predicted band size : 21 kDa
Observed band size : 24 kDa (why is the actual band size different from the predicted?)
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
